Disease/Infection News

RSS

Does cannabis use impact the risk of glaucoma? New study investigates

The study in Scientific Reports finds no significant association between cannabis use and the risk of primary open-angle glaucoma, challenging the notion that cannabis could influence intraocular pressure and glaucoma risk.

14 Nov 2023

COVID-19 triggers epigenetic alterations that drive lung damage and fatalities

The COVID-19 disease, due to infection with the SARS-CoV2 virus, became an international pandemic in 2020. To date, more than 770 million people have suffered from the disease and nearly 7 million of them have lost their life.

14 Nov 2023

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Republicans in Congress are "trying to wipe out federal funding to end the HIV epidemic."

14 Nov 2023

New research reveals broccoli sprouts may alleviate Crohn's disease symptoms in youth

The impact of broccoli sprouts and its role in resolving Crohn’s disease symptoms.

14 Nov 2023

Study observes virologic rebound in 20% of COVID-19 patients treated with nirmatrelvir-ritonavir

An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20 percent of patients treated with nirmatrelvir-ritonavir (N-R) versus about 2 percent of those who did not receive treatment. The findings are published in Annals of Internal Medicine.

13 Nov 2023

Study shows environment's pivotal role in healthy aging and disease prevention

Study explores new geroscience tools for studying the impact of environmental factors on aging, aiming to delay age-related diseases and disabilities. It highlights how non-genetic factors, like environmental toxins and socio-economic conditions, significantly influence aging and health outcomes.

13 Nov 2023

Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors

The study in JAMA Network Open evaluates the effectiveness of simultaneously administering the Pfizer-BioNTech BNT162b2 BA.4/5 COVID-19 vaccine and seasonal influenza vaccines versus separate administration. Results suggest similar or slightly increased COVID-19 outcomes and lower influenza-related outcomes with coadministration, particularly in those aged 65 and above.

13 Nov 2023

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test - a phenomenon known as virologic rebound.

13 Nov 2023

Hospital-acquired COVID-19 mortality drops in Omicron era post-vaccination, reveals Swedish study

In a study published in JAMA Network Open, researchers found that hospital-acquired SARS-CoV-2 infections in Stockholm led to increased 30-day mortality in the pre-vaccination period but showed significantly lower mortality during the Omicron wave post-vaccination. The study underscores the importance of vaccination in reducing mortality risks from nosocomial SARS-CoV-2 infections.

13 Nov 2023

Study unravels the molecular mechanisms underlying influenza B virus pathogenicity

Announcing a new article publication for Zoonoses journal. Influenza B virus is a significant respiratory pathogen responsible for seasonal influenza.

13 Nov 2023

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

In a JAMA Network Open study, researchers found no evidence of neuroinflammation or blood-brain barrier dysfunction in cerebrospinal fluid markers of individuals with post-COVID-19 condition and neuropsychiatric symptoms compared to controls. The study, which assessed cytokines, chemokines, and neuroinflammation markers, suggests that persistent central nervous system immune activation may not be the primary driver of neurological long COVID symptoms.

13 Nov 2023

Study uncovers how COVID-19 pandemic created new social disparities and affected existing inequalities

An article by Stockholm University researchers was recently published in the Proceedings of the National Academy of Sciences (PNAS).

13 Nov 2023

Study sheds light on role of antibodies in vaccine protection against COVID-19 variants

Efforts to contain the Covid-19 pandemic have largely focused on vaccine development and deployment. But how exactly do our immune systems respond to COVID-19 vaccines?

13 Nov 2023

New hope for TB patients as UNITE4TB launches clinical trial program

Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative Tuberculosis (TB) treatments, announced the start of its phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa.

13 Nov 2023

Open-science triumph: Crowdsourced initiative yields potent SARS-CoV-2 antivirals

In this study, researchers harnessed crowdsourcing and open science to develop new antivirals against SARS-CoV-2, focusing on its main protease, Mpro. Their approach led to the discovery of potent compounds, including one with high efficacy in cell lines and cross-reactivity against various COVID-19 variants, demonstrating the potential of collaborative and transparent drug discovery in tackling global health crises.

12 Nov 2023

Diverse gut bacteria could help fight cryptosporidiosis

The severity of a diarrheal disease could be down to the bacteria in your gut - according to new research from the University of East Anglia.

10 Nov 2023

Associations between screen time, exercise habits, and the onset of dementia, Parkinson's disease, and depression

Researchers explore the prospective link between screen time and the risk of developing dementia, Parkinson's disease, and depression.

10 Nov 2023

Is obesity an independent risk factor for cardiovascular disease?

Researchers explore how obesity contributes to cardiovascular disease by investigating this association in low-risk people.

10 Nov 2023

Mucosal vaccine shows lasting defense against SARS-CoV-2 Omicron in primate study

In this groundbreaking study, researchers developed a mucosal adenoviral-vector vaccine, ChAd-SARS-CoV-2-S, which demonstrated sustained and robust immunity against a challenging Omicron variant in nonhuman primates, indicating a promising direction for durable COVID-19 protection strategies. Unlike traditional intramuscular vaccines, this mucosal vaccine elicited a comprehensive immune response, potentially paving the way for more effective and long-lasting COVID-19 vaccines.

9 Nov 2023

Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in "Pediatric Research" examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

9 Nov 2023

Disease/Infection News

Does cannabis use impact the risk of glaucoma? New study investigates

COVID-19 triggers epigenetic alterations that drive lung damage and fatalities

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

New research reveals broccoli sprouts may alleviate Crohn's disease symptoms in youth

Study observes virologic rebound in 20% of COVID-19 patients treated with nirmatrelvir-ritonavir

Study shows environment's pivotal role in healthy aging and disease prevention

Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

Hospital-acquired COVID-19 mortality drops in Omicron era post-vaccination, reveals Swedish study

Study unravels the molecular mechanisms underlying influenza B virus pathogenicity

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

Study uncovers how COVID-19 pandemic created new social disparities and affected existing inequalities

Study sheds light on role of antibodies in vaccine protection against COVID-19 variants

New hope for TB patients as UNITE4TB launches clinical trial program

Open-science triumph: Crowdsourced initiative yields potent SARS-CoV-2 antivirals

Diverse gut bacteria could help fight cryptosporidiosis

Associations between screen time, exercise habits, and the onset of dementia, Parkinson's disease, and depression

Is obesity an independent risk factor for cardiovascular disease?

Mucosal vaccine shows lasting defense against SARS-CoV-2 Omicron in primate study

Pediatric viral threats surge in the 21st century: A call for One Health approach

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News